151
|
Adler SS, Afanasiev S, Aidala C, Ajitanand NN, Akiba Y, Alexander J, Amirikas R, Aphecetche L, Aronson SH, Averbeck R, Awes TC, Azmoun R, Babintsev V, Baldisseri A, Barish KN, Barnes PD, Bassalleck B, Bathe S, Batsouli S, Baublis V, Bazilevsky A, Belikov S, Berdnikov Y, Bhagavatula S, Boissevain JG, Borel H, Borenstein S, Brooks ML, Brown DS, Bruner N, Bucher D, Buesching H, Bumazhnov V, Bunce G, Burward-Hoy JM, Butsyk S, Camard X, Chai JS, Chand P, Chang WC, Chernichenko S, Chi CY, Chiba J, Chiu M, Choi IJ, Choi J, Choudhury RK, Chujo T, Cianciolo V, Cobigo Y, Cole BA, Constantin P, d'Enterria DG, David G, Delagrange H, Denisov A, Deshpande A, Desmond EJ, Dietzsch O, Drapier O, Drees A, du Rietz R, Durum A, Dutta D, Efremenko YV, El Chenawi K, Enokizono A, En'yo H, Esumi S, Ewell L, Fields DE, Fleuret F, Fokin SL, Fox BD, Fraenkel Z, Frantz JE, Franz A, Frawley AD, Fung SY, Garpman S, Ghosh TK, Glenn A, Gogiberidze G, Gonin M, Gosset J, Goto Y, Granier de Cassagnac R, Grau N, Greene SV, Grosse Perdekamp M, Guryn W, Gustafsson HA, Hachiya T, Haggerty JS, Hamagaki H, Hansen AG, Hartouni EP, Harvey M, Hayano R, He X, Heffner M, Hemmick TK, Heuser JM, Hibino M, Hill JC, Holzmann W, Homma K, Hong B, Hoover A, Ichihara T, Ikonnikov VV, Imai K, Isenhower D, Ishihara M, Issah M, Isupov A, Jacak BV, Jang WY, Jeong Y, Jia J, Jinnouchi O, Johnson BM, Johnson SC, Joo KS, Jouan D, Kametani S, Kamihara N, Kang JH, Kapoor SS, Katou K, Kelly S, Khachaturov B, Khanzadeev A, Kikuchi J, Kim DH, Kim DJ, Kim DW, Kim E, Kim GB, Kim HJ, Kistenev E, Kiyomichi A, Kiyoyama K, Klein-Boesing C, Kobayashi H, Kochenda L, Kochetkov V, Koehler D, Kohama T, Kopytine M, Kotchetkov D, Kozlov A, Kroon PJ, Kuberg CH, Kurita K, Kuroki Y, Kweon MJ, Kwon Y, Kyle GS, Lacey R, Ladygin V, Lajoie JG, Lebedev A, Leckey S, Lee DM, Lee S, Leitch MJ, Li XH, Lim H, Litvinenko A, Liu MX, Liu Y, Maguire CF, Makdisi YI, Malakhov A, Manko VI, Mao Y, Martinez G, Marx MD, Masui H, Matathias F, Matsumoto T, McGaughey PL, Melnikov E, Messer F, Miake Y, Milan J, Miller TE, Milov A, Mioduszewski S, Mischke RE, Mishra GC, Mitchell JT, Mohanty AK, Morrison DP, Moss JM, Mühlbacher F, Mukhopadhyay D, Muniruzzaman M, Murata J, Nagamiya S, Nagle JL, Nakamura T, Nandi BK, Nara M, Newby J, Nilsson P, Nyanin AS, Nystrand J, O'Brien E, Ogilvie CA, Ohnishi H, Ojha ID, Okada K, Ono M, Onuchin V, Oskarsson A, Otterlund I, Oyama K, Ozawa K, Pal D, Palounek APT, Pantuev VS, Papavassiliou V, Park J, Parmar A, Pate SF, Peitzmann T, Peng JC, Peresedov V, Pinkenburg C, Pisani RP, Plasil F, Purschke ML, Purwar AK, Rak J, Ravinovich I, Read KF, Reuter M, Reygers K, Riabov V, Riabov Y, Roche G, Romana A, Rosati M, Rosnet P, Ryu SS, Sadler ME, Saito N, Sakaguchi T, Sakai M, Sakai S, Samsonov V, Sanfratello L, Santo R, Sato HD, Sato S, Sawada S, Schutz Y, Semenov V, Seto R, Shaw MR, Shea TK, Shibata TA, Shigaki K, Shiina T, Silva CL, Silvermyr D, Sim KS, Singh CP, Singh V, Sivertz M, Soldatov A, Soltz RA, Sondheim WE, Sorensen SP, Sourikova IV, Staley F, Stankus PW, Stenlund E, Stepanov M, Ster A, Stoll SP, Sugitate T, Sullivan JP, Takagui EM, Taketani A, Tamai M, Tanaka KH, Tanaka Y, Tanida K, Tannenbaum MJ, Tarján P, Tepe JD, Thomas TL, Tojo J, Torii H, Towell RS, Tserruya I, Tsuruoka H, Tuli SK, Tydesjö H, Tyurin N, van Hecke HW, Velkovska J, Velkovsky M, Villatte L, Vinogradov AA, Volkov MA, Vznuzdaev E, Wang XR, Watanabe Y, White SN, Wohn FK, Woody CL, Xie W, Yang Y, Yanovich A, Yokkaichi S, Young GR, Yushmanov IE, Zajc WA, Zhang C, Zhou S, Zhou SJ, Zolin L. Measurement of nonrandom event-by-event fluctuations of average transverse momentum in square root of (sNN)=200 GeV Au+Au and p+p collisions. Phys Rev Lett 2004; 93:092301. [PMID: 15447093 DOI: 10.1103/physrevlett.93.092301] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/06/2003] [Indexed: 05/24/2023]
Abstract
Event-by-event fluctuations of the average transverse momentum of produced particles near midrapidity have been measured by the PHENIX Collaboration in square root of (sNN)=200 GeV Au+Au, and p+p collisions at the Relativistic Heavy Ion Collider. The fluctuations are observed to be in excess of the expectation for statistically independent particle emission for all centralities. The excess fluctuations exhibit a dependence on both the centrality of the collision and on the pT range over which the average is calculated. Both the centrality and pT dependence can be well reproduced by a simulation of random particle production with the addition of contributions from hard-scattering processes.
Collapse
Affiliation(s)
- S S Adler
- Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
152
|
Adler SS, Afanasiev S, Aidala C, Ajitanand NN, Akiba Y, Alexander J, Amirikas R, Aphecetche L, Aronson SH, Averbeck R, Awes TC, Azmoun R, Babintsev V, Baldisseri A, Barish KN, Barnes PD, Bassalleck B, Bathe S, Batsouli S, Baublis V, Bazilevsky A, Belikov S, Berdnikov Y, Bhagavatula S, Boissevain JG, Borel H, Borenstein S, Brooks ML, Brown DS, Bruner N, Bucher D, Buesching H, Bumazhnov V, Bunce G, Burward-Hoy JM, Butsyk S, Camard X, Chai JS, Chand P, Chang WC, Chernichenko S, Chi CY, Chiba J, Chiu M, Choi IJ, Choi J, Choudhury RK, Chujo T, Cianciolo V, Cobigo Y, Cole BA, Constantin P, d'Enterria DG, David G, Delagrange H, Denisov A, Deshpande A, Desmond EJ, Dietzsch O, Drapier O, Drees A, Drees KA, du Rietz R, Durum A, Dutta D, Efremenko YV, El-Chenawi K, Enokizono A, En'yo H, Esumi S, Ewell L, Fields DE, Fleuret F, Fokin SL, Fox BD, Fraenkel Z, Frantz JE, Franz A, Frawley AD, Fung SY, Garpman S, Ghosh TK, Glenn A, Gogiberidze G, Gonin M, Gosset J, Goto Y, Granier de Cassagnac R, Grau N, Greene SV, Grosse Perdekamp M, Guryn W, Gustafsson HA, Hachiya T, Haggerty JS, Hamagaki H, Hansen AG, Hartouni EP, Harvey M, Hayano R, He X, Heffner M, Hemmick TK, Heuser JM, Hibino M, Hill JC, Holzmann W, Homma K, Hong B, Hoover A, Ichihara T, Ikonnikov VV, Imai K, Isenhower D, Ishihara M, Issah M, Isupov A, Jacak BV, Jang WY, Jeong Y, Jia J, Jinnouchi O, Johnson BM, Johnson SC, Joo KS, Jouan D, Kametani S, Kamihara N, Kang JH, Kapoor SS, Katou K, Kelly S, Khachaturov B, Khanzadeev A, Kikuchi J, Kim DH, Kim DJ, Kim DW, Kim E, Kim GB, Kim HJ, Kistenev E, Kiyomichi A, Kiyoyama K, Klein-Boesing C, Kobayashi H, Kochenda L, Kochetkov V, Koehler D, Kohama T, Kopytine M, Kotchetkov D, Kozlov A, Kroon PJ, Kuberg CH, Kurita K, Kuroki Y, Kweon MJ, Kwon Y, Kyle GS, Lacey R, Ladygin V, Lajoie JG, Lebedev A, Leckey S, Lee DM, Lee S, Leitch MJ, Li XH, Lim H, Litvinenko A, Liu MX, Liu Y, Maguire CF, Makdisi YI, Malakhov A, Manko VI, Mao Y, Martinez G, Marx MD, Masui H, Matathias F, Matsumoto T, McGaughey PL, Melnikov E, Messer F, Miake Y, Milan J, Miller TE, Milov A, Mioduszewski S, Mischke RE, Mishra GC, Mitchell JT, Mohanty AK, Morrison DP, Moss JM, Mühlbacher F, Mukhopadhyay D, Muniruzzaman M, Murata J, Nagamiya S, Nagle JL, Nakamura T, Nandi BK, Nara M, Newby J, Nilsson P, Nyanin AS, Nystrand J, O'Brien E, Ogilvie CA, Ohnishi H, Ojha ID, Okada K, Ono M, Onuchin V, Oskarsson A, Otterlund I, Oyama K, Ozawa K, Pal D, Palounek APT, Pantuev VS, Papavassiliou V, Park J, Parmar A, Pate SF, Peitzmann T, Peng JC, Peresedov V, Pinkenburg C, Pisani RP, Plasil F, Purschke ML, Purwar AK, Rak J, Ravinovich I, Read KF, Reuter M, Reygers K, Riabov V, Riabov Y, Roche G, Romana A, Rosati M, Rosnet P, Ryu SS, Sadler ME, Saito N, Sakaguchi T, Sakai M, Sakai S, Samsonov V, Sanfratello L, Santo R, Sato HD, Sato S, Sawada S, Schutz Y, Semenov V, Seto R, Shaw MR, Shea TK, Shibata TA, Shigaki K, Shiina T, Silva CL, Silvermyr D, Sim KS, Singh CP, Singh V, Sivertz M, Soldatov A, Soltz RA, Sondheim WE, Sorensen SP, Sourikova IV, Staley F, Stankus PW, Stenlund E, Stepanov M, Ster A, Stoll SP, Sugitate T, Sullivan JP, Takagui EM, Taketani A, Tamai M, Tanaka KH, Tanaka Y, Tanida K, Tannenbaum MJ, Tarján P, Tepe JD, Thomas TL, Tojo J, Torii H, Towell RS, Tserruya I, Tsuruoka H, Tuli SK, Tydesjö H, Tyurin N, van Hecke HW, Velkovska J, Velkovsky M, Villatte L, Vinogradov AA, Volkov MA, Vznuzdaev E, Wang XR, Watanabe Y, White SN, Wohn FK, Woody CL, Xie W, Yang Y, Yanovich A, Yokkaichi S, Young GR, Yushmanov IE, Zajc WA, Zhang C, Zhou S, Zhou SJ, Zolin L. J/psi production from proton-proton collisions at square root of s=200 GeV. Phys Rev Lett 2004; 92:051802. [PMID: 14995296 DOI: 10.1103/physrevlett.92.051802] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/08/2003] [Indexed: 05/24/2023]
Abstract
J/psi production has been measured in proton-proton collisions at square root of s=200 GeV over a wide rapidity and transverse momentum range by the PHENIX experiment at the Relativistic Heavy Ion Collider. Distributions of the rapidity and transverse momentum, along with measurements of the mean transverse momentum and total production cross section are presented and compared to available theoretical calculations. The total J/psi cross section is 4.0+/-0.6(stat)+/-0.6(syst)+/-0.4(abs) mu b. The mean transverse momentum is 1.80+/-0.23(stat)+/-0.16(syst) GeV/c.
Collapse
Affiliation(s)
- S S Adler
- Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
153
|
Abstract
AIM The application of sentinel node (SN) biopsy in gastric cancer remains controversial. In this study, detection rate and predictive values of SN biopsy were determined to evaluate its feasibility in gastric cancer. Various clinicopathologic features were also analysed to determine the factors affecting the detection rate and predictive values. METHODS Seventy-one gastric adenocarcinoma patients without serosal invasion and distant metastasis, were studied. One percent isosulfan blue stained nodes were defined as SNs, and standard gastrectomy with D2 lymphadenectomy was performed. All lymph nodes were studied by hematoxylin and eosin staining. RESULTS SNs were identified in 65 of 71 patients and average number of SNs per patient was 2.5 (range 1-8). Among the 65 patients with SNs, metastatic SNs were found in 11 and the remaining 54 were free of metastasis. In eight of the 11 patients with metastasis of the SNs, metastases were also identified in non-SNs. CONCLUSIONS SN biopsy is feasible in early stage gastric cancer. However, complementary procedures may be needed to improve the detection rate and predictive values. SNs biopsy results should be treated with caution in male patients and for tumours at the upper part of stomach due to the low detection rate.
Collapse
Affiliation(s)
- K W Ryu
- Research Institute and Hospital, National Cancer Center, 809 Madu-dong, Ilsan-gu, Goyang, Gyeonggi 411-764, South Korea.
| | | | | | | | | | | |
Collapse
|
154
|
Adler SS, Afanasiev S, Aidala C, Ajitanand NN, Akiba Y, Alexander J, Amirikas R, Aphecetche L, Aronson SH, Averbeck R, Awes TC, Azmoun R, Babintsev V, Baldisseri A, Barish KN, Barnes PD, Bassalleck B, Bathe S, Batsouli S, Baublis V, Bazilevsky A, Belikov S, Berdnikov Y, Bhagavatula S, Boissevain JG, Borel H, Borenstein S, Brooks ML, Brown DS, Bruner N, Bucher D, Buesching H, Bumazhnov V, Bunce G, Burward-Hoy JM, Butsyk S, Camard X, Chai JS, Chand P, Chang WC, Chernichenko S, Chi CY, Chiba J, Chiu M, Choi IJ, Choi J, Choudhury RK, Chujo T, Cianciolo V, Cobigo Y, Cole BA, Constantin P, D'Enterria DG, David G, Delagrange H, Denisov A, Deshpande A, Desmond EJ, Dietzsch O, Drapier O, Drees A, Drees KA, Du Rietz R, Durum A, Dutta D, Efremenko YV, El Chenawi K, Enokizono A, En'yo H, Esumi S, Ewell L, Fields DE, Fleuret F, Fokin SL, Fox BD, Fraenkel Z, Frantz JE, Franz A, Frawley AD, Fung SY, Garpman S, Ghosh TK, Glenn A, Gogiberidze G, Gonin M, Gosset J, Goto Y, Granier De Cassagnac R, Grau N, Greene SV, Grosse Perdekamp M, Guryn W, Gustafsson HA, Hachiya T, Haggerty JS, Hamagaki H, Hansen AG, Hartouni EP, Harvey M, Hayano R, He X, Heffner M, Hemmick TK, Heuser JM, Hibino M, Hill JC, Holzmann W, Homma K, Hong B, Hoover A, Ichihara T, Ikonnikov VV, Imai K, Isenhower D, Ishihara M, Issah M, Isupov A, Jacak BV, Jang WY, Jeong Y, Jia J, Jinnouchi O, Johnson BM, Johnson SC, Joo KS, Jouan D, Kametani S, Kamihara N, Kang JH, Kapoor SS, Katou K, Kelly S, Khachaturov B, Khanzadeev A, Kikuchi J, Kim DH, Kim DJ, Kim DW, Kim E, Kim GB, Kim HJ, Kistenev E, Kiyomichi A, Kiyoyama K, Klein-Boesing C, Kobayashi H, Kochenda L, Kochetkov V, Koehler D, Kohama T, Kopytine M, Kotchetkov D, Kozlov A, Kroon PJ, Kuberg CH, Kurita K, Kuroki Y, Kweon MJ, Kwon Y, Kyle GS, Lacey R, Ladygin V, Lajoie JG, Lebedev A, Leckey S, Lee DM, Lee S, Leitch MJ, Li XH, Lim H, Litvinenko A, Liu MX, Liu Y, Maguire CF, Makdisi YI, Malakhov A, Manko VI, Mao Y, Martinez G, Marx MD, Masui H, Matathias F, Matsumoto T, McGaughey PL, Melnikov E, Messer F, Miake Y, Milan J, Miller TE, Milov A, Mioduszewski S, Mischke RE, Mishra GC, Mitchell JT, Mohanty AK, Morrison DP, Moss JM, Mühlbacher F, Mukhopadhyay D, Muniruzzaman M, Murata J, Nagamiya S, Nagle JL, Nakamura T, Nandi BK, Nara M, Newby J, Nilsson P, Nyanin AS, Nystrand J, O'Brien E, Ogilvie CA, Ohnishi H, Ojha ID, Okada K, Ono M, Onuchin V, Oskarsson A, Otterlund I, Oyama K, Ozawa K, Pal D, Palounek APT, Pantuev VS, Papavassiliou V, Park J, Parmar A, Pate SF, Peitzmann T, Peng JC, Peresedov V, Pinkenburg C, Pisani RP, Plasil F, Purschke ML, Purwar AK, Rak J, Ravinovich I, Read KF, Reuter M, Reygers K, Riabov V, Riabov Y, Roche G, Romana A, Rosati M, Rosnet P, Ryu SS, Sadler ME, Saito N, Sakaguchi T, Sakai M, Sakai S, Samsonov V, Sanfratello L, Santo R, Sato HD, Sato S, Sawada S, Schutz Y, Semenov V, Seto R, Shaw MR, Shea TK, Shibata TA, Shigaki K, Shiina T, Silva CL, Silvermyr D, Sim KS, Singh CP, Singh V, Sivertz M, Soldatov A, Soltz RA, Sondheim WE, Sorensen SP, Sourikova IV, Staley F, Stankus PW, Stenlund E, Stepanov M, Ster A, Stoll SP, Sugitate T, Sullivan JP, Takagui EM, Taketani A, Tamai M, Tanaka KH, Tanaka Y, Tanida K, Tannenbaum MJ, Tarján P, Tepe JD, Thomas TL, Tojo J, Torii H, Towell RS, Tserruya I, Tsuruoka H, Tuli SK, Tydesjö H, Tyurin N, Van Hecke HW, Velkovska J, Velkovsky M, Villatte L, Vinogradov AA, Volkov MA, Vznuzdaev E, Wang XR, Watanabe Y, White SN, Wohn FK, Woody CL, Xie W, Yang Y, Yanovich A, Yokkaichi S, Young GR, Yushmanov IE, Zajc WA, Zhang C, Zhou S, Zolin L. Midrapidity neutral-pion production in proton-proton collisions at square root s = 200 GeV. Phys Rev Lett 2003; 91:241803. [PMID: 14683109 DOI: 10.1103/physrevlett.91.241803] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/28/2003] [Indexed: 05/24/2023]
Abstract
The invariant differential cross section for inclusive neutral-pion production in p+p collisions at sqrt[s]=200 GeV has been measured at midrapidity (|eta|<0.35) over the range 1<p(T) less, similar 14 GeV/c by the PHENIX experiment at the Relativistic Heavy Ion Collider. Predictions of next-to-leading order perturbative QCD calculations are consistent with these measurements. The precision of our result is sufficient to differentiate between prevailing gluon-to-pion fragmentation functions.
Collapse
Affiliation(s)
- S S Adler
- Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
155
|
Adler SS, Afanasiev S, Aidala C, Ajitanand NN, Akiba Y, Alexander J, Amirikas R, Aphecetche L, Aronson SH, Averbeck R, Awes TC, Azmoun R, Babintsev V, Baldisseri A, Barish KN, Barnes PD, Bassalleck B, Bathe S, Batsouli S, Baublis V, Bazilevsky A, Belikov S, Berdnikov Y, Bhagavatula S, Boissevain JG, Borel H, Borenstein S, Brooks ML, Brown DS, Bruner N, Bucher D, Buesching H, Bumazhnov V, Bunce G, Burward-Hoy JM, Butsyk S, Camard X, Chai JS, Chand P, Chang WC, Chernichenko S, Chi CY, Chiba J, Chiu M, Choi IJ, Choi J, Choudhury RK, Chujo T, Cianciolo V, Cobigo Y, Cole BA, Constantin P, D'Enterria DG, David G, Delagrange H, Denisov A, Deshpande A, Desmond EJ, Dietzsch O, Drapier O, Drees A, du Rietz R, Durum A, Dutta D, Efremenko YV, El Chenawi K, Enokizono A, En'yo H, Esumi S, Ewell L, Fields DE, Fleuret F, Fokin SL, Fox BD, Fraenkel Z, Frantz JE, Franz A, Frawley AD, Fung SY, Garpman S, Ghosh TK, Glenn A, Gogiberidze G, Gonin M, Gosset J, Goto Y, Granier de Cassagnac R, Grau N, Greene SV, Grosse Perdekamp M, Guryn W, Gustafsson HA, Hachiya T, Haggerty JS, Hamagaki H, Hansen AG, Hartouni EP, Harvey M, Hayano R, He X, Heffner M, Hemmick TK, Heuser JM, Hibino M, Hill JC, Holzmann W, Homma K, Hong B, Hoover A, Ichihara T, Ikonnikov VV, Imai K, Isenhower LD, Ishihara M, Issah M, Isupov A, Jacak BV, Jang WY, Jeong Y, Jia J, Jinnouchi O, Johnson BM, Johnson SC, Joo KS, Jouan D, Kametani S, Kamihara N, Kang JH, Kapoor SS, Katou K, Kelly S, Khachaturov B, Khanzadeev A, Kikuchi J, Kim DH, Kim DJ, Kim DW, Kim E, Kim GB, Kim HJ, Kistenev E, Kiyomichi A, Kiyoyama K, Klein-Boesing C, Kobayashi H, Kochenda L, Kochetkov V, Koehler D, Kohama T, Kopytine M, Kotchetkov D, Kozlov A, Kroon PJ, Kuberg CH, Kurita K, Kuroki Y, Kweon MJ, Kwon Y, Kyle GS, Lacey R, Ladygin V, Lajoie JG, Lebedev A, Leckey S, Lee DM, Lee S, Leitch MJ, Li XH, Lim H, Litvinenko A, Liu MX, Liu Y, Maguire CF, Makdisi YI, Malakhov A, Manko VI, Mao Y, Martinez G, Marx MD, Masui H, Matathias F, Matsumoto T, McGaughey PL, Melnikov E, Messer F, Miake Y, Milan J, Miller TE, Milov A, Mioduszewski S, Mischke RE, Mishra GC, Mitchell JT, Mohanty AK, Morrison DP, Moss JM, Mühlbacher F, Mukhopadhyay D, Muniruzzaman M, Murata J, Nagamiya S, Nagle JL, Nakamura T, Nandi BK, Nara M, Newby J, Nilsson P, Nyanin AS, Nystrand J, O'Brien E, Ogilvie CA, Ohnishi H, Ojha ID, Okada K, Ono M, Onuchin V, Oskarsson A, Otterlund I, Oyama K, Ozawa K, Pal D, Palounek APT, Pantuev VS, Papavassiliou V, Park J, Parmar A, Pate SF, Peitzmann T, Peng JC, Peresedov V, Pinkenburg C, Pisani RP, Plasil F, Purschke ML, Purwar A, Rak J, Ravinovich I, Read KF, Reuter M, Reygers K, Riabov V, Riabov Y, Roche G, Romana A, Rosati M, Rosnet P, Ryu SS, Sadler ME, Saito N, Sakaguchi T, Sakai M, Sakai S, Samsonov V, Sanfratello L, Santo R, Sato HD, Sato S, Sawada S, Schutz Y, Semenov V, Seto R, Shaw MR, Shea TK, Shibata TA, Shigaki K, Shiina T, Silva CL, Silvermyr D, Sim KS, Singh CP, Singh V, Sivertz M, Soldatov A, Soltz RA, Sondheim WE, Sorensen SP, Sourikova IV, Staley F, Stankus PW, Stenlund E, Stepanov M, Ster A, Stoll SP, Sugitate T, Sullivan JP, Takagui EM, Taketani A, Tamai M, Tanaka KH, Tanaka Y, Tanida K, Tannenbaum MJ, Tarján P, Tepe JD, Thomas TL, Tojo J, Torii H, Towell RS, Tserruya I, Tsuruoka H, Tuli SK, Tydesjö H, Tyurin N, van Hecke HW, Velkovska J, Velkovsky M, Villatte L, Vinogradov AA, Volkov MA, Vznuzdaev E, Wang XR, Watanabe Y, White SN, Wohn FK, Woody CL, Xie W, Yang Y, Yanovich A, Yokkaichi S, Young GR, Yushmanov IE, Zajc WA, Zhang C, Zhou S, Zolin L. Elliptic flow of identified hadrons in Au+Au collisions at sqrt sNN =200 GeV. Phys Rev Lett 2003; 91:182301. [PMID: 14611277 DOI: 10.1103/physrevlett.91.182301] [Citation(s) in RCA: 32] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/16/2003] [Indexed: 05/24/2023]
Abstract
The anisotropy parameter (v(2)), the second harmonic of the azimuthal particle distribution, has been measured with the PHENIX detector in Au+Au collisions at sqrt[s(NN)]=200 GeV for identified and inclusive charged particle production at central rapidities (|eta|<0.35) with respect to the reaction plane defined at high rapidities (|eta|=3-4 ). We observe that the v(2) of mesons falls below that of (anti)baryons for p(T)>2 GeV/c, in marked contrast to the predictions of a hydrodynamical model. A quark-coalescence model is also investigated.
Collapse
Affiliation(s)
- S S Adler
- Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
156
|
Adler SS, Afanasiev S, Aidala C, Ajitanand NN, Akiba Y, Alexander J, Amirikas R, Aphecetche L, Aronson SH, Averbeck R, Awes TC, Azmoun R, Babintsev V, Baldisseri A, Barish KN, Barnes PD, Bassalleck B, Bathe S, Batsouli S, Baublis V, Bazilevsky A, Belikov S, Berdnikov Y, Bhagavatula S, Boissevain JG, Borel H, Borenstein S, Brooks ML, Brown DS, Bruner N, Bucher D, Buesching H, Bumazhnov V, Bunce G, Burward-Hoy JM, Butsyk S, Camard X, Chai JS, Chand P, Chang WC, Chernichenko S, Chi CY, Chiba J, Chiu M, Choi IJ, Choi J, Choudhury RK, Chujo T, Cianciolo V, Cobigo Y, Cole BA, Constantin P, d'Enterria DG, David G, Delagrange H, Denisov A, Deshpande A, Desmond EJ, Dietzsch O, Drapier O, Drees A, du Rietz R, Durum A, Dutta D, Efremenko YV, El Chenawi K, Enokizono A, En'yo H, Esumi S, Ewell L, Fields DE, Fleuret F, Fokin SL, Fox BD, Fraenkel Z, Frantz JE, Franz A, Frawley AD, Fung SY, Garpman S, Ghosh TK, Glenn A, Gogiberidze G, Gonin M, Gosset J, Goto Y, Granier de Cassagnac R, Grau N, Greene SV, Grosse Perdekamp G, Guryn W, Gustafsson HA, Hachiya T, Haggerty JS, Hamagaki H, Hansen AG, Hartouni EP, Harvey M, Hayano R, He X, Heffner M, Hemmick TK, Heuser JM, Hibino M, Hill JC, Holzmann W, Homma K, Hong B, Hoover A, Ichihara T, Ikonnikov VV, Imai K, Isenhower LD, Ishihara M, Issah M, Isupov A, Jacak BV, Jang WY, Jeong Y, Jia J, Jinnouchi O, Johnson BM, Johnson SC, Joo KS, Jouan D, Kametani S, Kamihara N, Kang JH, Kapoor SS, Katou K, Kelly S, Khachaturov B, Khanzadeev A, Kikuchi J, Kim DH, Kim DJ, Kim DW, Kim E, Kim GB, Kim HJ, Kistenev E, Kiyomichi A, Kiyoyama K, Klein-Boesing C, Kobayashi H, Kochenda L, Kochetkov V, Koehler D, Kohama T, Kopytine M, Kotchetkov D, Kozlov A, Kroon PJ, Kuberg CH, Kurita K, Kuroki Y, Kweon MJ, Kwon Y, Kyle GS, Lacey R, Ladygin V, Lajoie JG, Lebedev A, Leckey S, Lee DM, Lee S, Leitch MJ, Li XH, Lim H, Litvinenko A, Liu MX, Liu Y, Maguire CF, Makdisi YI, Malakhov A, Manko VI, Mao Y, Martinez G, Marx MD, Masui H, Matathias F, Matsumoto T, McGaughey PL, Melnikov E, Messer F, Miake Y, Milan J, Miller TE, Milov A, Mioduszewski S, Mischke RE, Mishra GC, Mitchell JT, Mohanty AK, Morrison DP, Moss JM, Mühlbacher F, Mukhopadhyay D, Muniruzzaman M, Murata J, Nagamiya S, Nagle JL, Nakamura T, Nandi BK, Nara M, Newby J, Nilsson P, Nyanin AS, Nystrand J, O'Brien E, Ogilvie CA, Ohnishi H, Ojha ID, Okada K, Ono M, Onuchin V, Oskarsson A, Otterlund I, Oyama K, Ozawa K, Pal D, Palounek APT, Pantuev VS, Papavassiliou V, Park J, Parmar A, Pate SF, Peitzmann T, Peng JC, Peresedov V, Pinkenburg C, Pisani RP, Plasil F, Purschke ML, Purwar A, Rak J, Ravinovich I, Read KF, Reuter M, Reygers K, Riabov V, Riabov Y, Roche G, Romana A, Rosati M, Rosnet P, Ryu SS, Sadler ME, Saito N, Sakaguchi T, Sakai M, Sakai S, Samsonov V, Sanfratello L, Santo R, Sato HD, Sato S, Sawada S, Schutz Y, Semenov V, Seto R, Shaw MR, Shea TK, Shibata TA, Shigaki K, Shiina T, Silva CL, Silvermyr D, Sim KS, Singh CP, Singh V, Sivertz M, Soldatov A, Soltz RA, Sondheim WE, Sorensen SP, Sourikova IV, Staley F, Stankus PW, Stenlund E, Stepanov M, Ster A, Stoll SP, Sugitate T, Sullivan JP, Takagui EM, Taketani A, Tamai M, Tanaka KH, Tanaka Y, Tanida K, Tannenbaum MJ, Tarján P, Tepe JD, Thomas TL, Tojo J, Torii H, Towell RS, Tserruya I, Tsuruoka H, Tuli SK, Tydesjö H, Tyurin N, Van Hecke HW, Velkovska J, Velkovsky M, Villatte L, Vinogradov AA, Volkov MA, Vznuzdaev E, Wang XR, Watanabe Y, White SN, Wohn FK, Woody CL, Xie W, Yang Y, Yanovich A, Yokkaichi S, Young GR, Yushmanov IE, Zajc WA, Zhang C, Zhou S, Zolin L. Scaling properties of proton and antiproton production in sqrt[s(NN)]=200 GeV Au+Au collisions. Phys Rev Lett 2003; 91:172301. [PMID: 14611335 DOI: 10.1103/physrevlett.91.172301] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/30/2003] [Indexed: 05/24/2023]
Abstract
We report on the yield of protons and antiprotons, as a function of centrality and transverse momentum, in Au+Au collisions at sqrt[s(NN)]=200 GeV measured at midrapidity by the PHENIX experiment at the BNL Relativistic Heavy Ion Collider. In central collisions at intermediate transverse momenta (1.5<p(T)<4.5 GeV/c) a significant fraction of all produced particles are protons and antiprotons. They show a centrality-scaling behavior different from that of pions. The pmacr;/pi and p/pi ratios are enhanced compared to peripheral Au+Au, p+p, and e(+)e(-) collisions. This enhancement is limited to p(T)<5 GeV/c as deduced from the ratio of charged hadrons to pi(0) measured in the range 1.5<p(T)<9 GeV/c.
Collapse
Affiliation(s)
- S S Adler
- Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
157
|
Adler SS, Afanasiev S, Aidala C, Ajitanand NN, Akiba Y, Al-Jamel A, Alexander J, Aoki K, Aphecetche L, Armendariz R, Aronson SH, Averbeck R, Awes TC, Babintsev V, Baldisseri A, Barish KN, Barnes PD, Bassalleck B, Bathe S, Batsouli S, Baublis V, Bauer F, Bazilevsky A, Belikov S, Bjorndal MT, Boissevain JG, Borel H, Brooks ML, Brown DS, Bruner N, Bucher D, Buesching H, Bumazhnov V, Bunce G, Burward-Hoy JM, Butsyk S, Camard X, Chand P, Chang WC, Chernichenko S, Chi CY, Chiba J, Chiu M, Choi IJ, Choudhury RK, Chujo T, Cianciolo V, Cobigo Y, Cole BA, Comets MP, Constantin P, Csanád M, Csörgo T, Cussonneau JP, d'Enterria D, Das K, David G, Deák F, Delagrange H, Denisov A, Deshpande A, Desmond EJ, Devismes A, Dietzsch O, Drachenberg JL, Drapier O, Drees A, Durum A, Dutta D, Dzhordzhadze V, Efremenko YV, En'yo H, Espagnon B, Esumi S, Fields DE, Finck C, Fleuret F, Fokin SL, Fox BD, Fraenkel Z, Frantz JE, Franz A, Frawley AD, Fukao Y, Fung SY, Gadrat S, Germain M, Glenn A, Gonin M, Gosset J, Goto Y, Granier de Cassagnac R, Grau N, Greene SV, Grosse Perdekamp M, Gustafsson HA, Hachiya T, Haggerty JS, Hamagaki H, Hansen AG, Hartouni EP, Harvey M, Hasuko K, Hayano R, He X, Heffner M, Hemmick TK, Heuser JM, Hidas P, Hiejima H, Hill JC, Hobbs R, Holzmann W, Homma K, Hong B, Hoover A, Horaguchi T, Ichihara T, Ikonnikov VV, Imai K, Inuzuka M, Isenhower D, Isenhower L, Issah M, Isupov A, Jacak BV, Jia J, Jinnouchi O, Johnson BM, Johnson SC, Joo KS, Jouan D, Kajihara F, Kametani S, Kamihara N, Kaneta M, Kang JH, Katou K, Kawabata T, Kazantsev A, Kelly S, Khachaturov B, Khanzadeev A, Kikuchi J, Kim DJ, Kim E, Kim GB, Kim HJ, Kinney E, Kiss A, Kistenev E, Kiyomichi A, Klein-Boesing C, Kobayashi H, Kochetkov V, Kohara R, Komkov B, Konno M, Kotchetkov D, Kozlov A, Kroon PJ, Kuberg CH, Kunde GJ, Kurita K, Kweon MJ, Kwon Y, Kyle GS, Lacey R, Lajoie JG, Le Bornec Y, Lebedev A, Leckey S, Lee DM, Leitch MJ, Leite MAL, Li X, Li XH, Lim H, Litvinenko A, Liu MX, Maguire CF, Makdisi YI, Malakhov A, Manko VI, Mao Y, Martinez G, Masui H, Matathias F, Matsumoto T, McCain MC, McGaughey PL, Miake Y, Miller TE, Milov A, Mioduszewski S, Mishra GC, Mitchell JT, Mohanty AK, Morrison DP, Moss JM, Mukhopadhyay D, Muniruzzaman M, Nagamiya S, Nagle JL, Nakamura T, Newby J, Nyanin AS, Nystrand J, O'Brien E, Ogilvie CA, Ohnishi H, Ojha ID, Okada H, Okada K, Oskarsson A, Otterlund I, Oyama K, Ozawa K, Pal D, Palounek APT, Pantuev V, Papavassiliou V, Park J, Park WJ, Pate SF, Pei H, Penev V, Peng JC, Pereira H, Peresedov V, Pierson A, Pinkenburg C, Pisani RP, Purschke ML, Purwar AK, Qualls J, Rak J, Ravinovich I, Read KF, Reuter M, Reygers K, Riabov V, Riabov Y, Roche G, Romana A, Rosati M, Rosendahl S, Rosnet P, Rykov VL, Ryu SS, Saito N, Sakaguchi T, Sakai S, Samsonov V, Sanfratello L, Santo R, Sato HD, Sato S, Sawada S, Schutz Y, Semenov V, Seto R, Shea TK, Shein I, Shibata TA, Shigaki K, Shimomura M, Sickles A, Silva CL, Silvermyr D, Sim KS, Soldatov A, Soltz RA, Sondheim WE, Sorensen S, Sourikova IV, Staley F, Stankus PW, Stenlund E, Stepanov M, Ster A, Stoll SP, Sugitate T, Sullivan JP, Takagi S, Takagui EM, Taketani A, Tanaka KH, Tanaka Y, Tanida K, Tannenbaum MJ, Taranenko A, Tarján P, Thomas TL, Togawa M, Tojo J, Torii H, Towell RS, Tram VN, Tserruya I, Tsuchimoto Y, Tydesjö H, Tyurin N, Uam TJ, van Hecke HW, Velkovska J, Velkovsky M, Veszprémi V, Vinogradov AA, Volkov MA, Vznuzdaev E, Wang XR, Watanabe Y, White SN, Willis N, Wohn FK, Woody CL, Xie W, Yanovich A, Yokkaichi S, Young GR, Yushmanov IE, Zajc WA, Zhang C, Zhou S, Zimányi J, Zolin L, Zong X. Absence of suppression in particle production at large transverse momentum in sqrt[s(NN)]=200 GeV d+Au collisions. Phys Rev Lett 2003; 91:072303. [PMID: 12935008 DOI: 10.1103/physrevlett.91.072303] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/18/2003] [Indexed: 05/24/2023]
Abstract
Transverse momentum spectra of charged hadrons with p(T)<8 GeV/c and neutral pions with p(T)<10 GeV/c have been measured at midrapidity by the PHENIX experiment at BNL RHIC in d+Au collisions at sqrt[s(NN)]=200 GeV. The measured yields are compared to those in p+p collisions at the same sqrt[s(NN)] scaled up by the number of underlying nucleon-nucleon collisions in d+Au. The yield ratio does not show the suppression observed in central Au+Au collisions at RHIC. Instead, there is a small enhancement in the yield of high momentum particles.
Collapse
Affiliation(s)
- S S Adler
- Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
158
|
Adler SS, Afanasiev S, Aidala C, Ajitanand NN, Akiba Y, Alexander J, Amirikas R, Aphecetche L, Aronson SH, Averbeck R, Awes TC, Azmoun R, Babintsev V, Baldisseri A, Barish KN, Barnes PD, Bassalleck B, Bathe S, Batsouli S, Baublis V, Bazilevsky A, Belikov S, Berdnikov Y, Bhagavatula S, Boissevain JG, Borel H, Borenstein S, Brooks ML, Brown DS, Bruner N, Bucher D, Buesching H, Bumazhnov V, Bunce G, Burward-Hoy JM, Butsyk S, Camard X, Chai JS, Chand P, Chang WC, Chernichenko S, Chi CY, Chiba J, Chiu M, Choi IJ, Choi J, Choudhury RK, Chujo T, Cianciolo V, Cobigo Y, Cole BA, Constantin P, d'Enterria DG, David G, Delagrange H, Denisov A, Deshpande A, Desmond EJ, Dietzsch O, Drapier O, Drees A, Drees KA, du Rietz R, Durum A, Dutta D, Efremenko YV, El Chenawi K, Enokizono A, En'yo H, Esumi S, Ewell L, Fields DE, Fleuret F, Fokin SL, Fox BD, Fraenkel Z, Frantz JE, Franz A, Frawley AD, Fung SY, Garpman S, Ghosh TK, Glenn A, Gogiberidze G, Gonin M, Gosset J, Goto Y, Granier de Cassagnac R, Grau N, Greene SV, Grosse Perdekamp M, Guryn W, Gustafsson HA, Hachiya T, Haggerty JS, Hamagaki H, Hansen AG, Hartouni EP, Harvey M, Hayano R, He X, Heffner M, Hemmick TK, Heuser JM, Hibino M, Hill JC, Holzmann W, Homma K, Hong B, Hoover A, Ichihara T, Ikonnikov VV, Imai K, Isenhower L, Ishihara M, Issah M, Isupov A, Jacak BV, Jang WY, Jeong Y, Jia J, Jinnouchi O, Johnson BM, Johnson SC, Joo KS, Jouan D, Kametani S, Kamihara N, Kang JH, Kapoor SS, Katou K, Kelly S, Khachaturov B, Khanzadeev A, Kikuchi J, Kim DH, Kim DJ, Kim DW, Kim E, Kim GB, Kim HJ, Kistenev E, Kiyomichi A, Kiyoyama K, Klein-Boesing C, Kobayashi H, Kochenda L, Kochetkov V, Koehler D, Kohama T, Kopytine M, Kotchetkov D, Kozlov A, Kroon PJ, Kuberg CH, Kurita K, Kuroki Y, Kweon MJ, Kwon Y, Kyle GS, Lacey R, Ladygin V, Lajoie JG, Lebedev A, Leckey S, Lee DM, Lee S, Leitch MJ, Li XH, Lim H, Litvinenko A, Liu MX, Liu Y, Maguire CF, Makdisi YI, Malakhov A, Manko VI, Mao Y, Martinez G, Marx MD, Masui H, Matathias F, Matsumoto T, McGaughey PL, Melnikov E, Messer F, Miake Y, Milan J, Miller TE, Milov A, Mioduszewski S, Mischke RE, Mishra GC, Mitchell JT, Mohanty AK, Morrison DP, Moss JM, Mühlbacher F, Mukhopadhyay D, Muniruzzaman M, Murata J, Nagamiya S, Nagle JL, Nakamura T, Nandi BK, Nara M, Newby J, Nilsson P, Nyanin AS, Nystrand J, O'Brien E, Ogilvie CA, Ohnishi H, Ojha ID, Okada K, Ono M, Onuchin V, Oskarsson A, Otterlund I, Oyama K, Ozawa K, Pal D, Palounek APT, Pantuev VS, Papavassiliou V, Park J, Parmar A, Pate SF, Peitzmann T, Peng JC, Peresedov V, Pinkenburg C, Pisani RP, Plasil F, Purschke ML, Purwar AK, Rak J, Ravinovich I, Read KF, Reuter M, Reygers K, Riabov V, Riabov Y, Roche G, Romana A, Rosati M, Rosnet P, Ryu SS, Sadler ME, Saito N, Sakaguchi T, Sakai M, Sakai S, Samsonov V, Sanfratello L, Santo R, Sato HD, Sato S, Sawada S, Schutz Y, Semenov V, Seto R, Shaw MR, Shea TK, Shibata TA, Shigaki K, Shiina T, Silva CL, Silvermyr D, Sim KS, Singh CP, Singh V, Sivertz M, Soldatov A, Soltz RA, Sondheim WE, Sorensen SP, Sourikova IV, Staley F, Stankus PW, Stenlund E, Stepanov M, Ster A, Stoll SP, Sugitate T, Sullivan JP, Takagui EM, Taketani A, Tamai M, Tanaka KH, Tanaka Y, Tanida K, Tannenbaum MJ, Tarján P, Tepe JD, Thomas TL, Tojo J, Torii H, Towell RS, Tserruya I, Tsuruoka H, Tuli SK, Tydesjö H, Tyurin N, van Hecke HW, Velkovska J, Velkovsky M, Villatte L, Vinogradov AA, Volkov MA, Vznuzdaev E, Wang XR, Watanabe Y, White SN, Wohn FK, Woody CL, Xie W, Yang Y, Yanovich A, Yokkaichi S, Young GR, Yushmanov IE, Zajc WA, Zhang C, Zhou S, Zolin L. Suppressed pi(0) production at large transverse momentum in central Au+Au collisions at sqrt[s(NN)]=200 GeV. Phys Rev Lett 2003; 91:072301. [PMID: 12935006 DOI: 10.1103/physrevlett.91.072301] [Citation(s) in RCA: 50] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/28/2003] [Indexed: 05/24/2023]
Abstract
Transverse momentum spectra of neutral pions in the range 1<p(T)<10 GeV/c have been measured at midrapidity by the PHENIX experiment at BNL RHIC in Au+Au collisions at sqrt[s(NN)]=200 GeV. The pi(0) multiplicity in central reactions is significantly below the yields measured at the same sqrt[s(NN)] in peripheral Au+Au and p+p reactions scaled by the number of nucleon-nucleon collisions. For the most central bin, the suppression factor is approximately 2.5 at p(T)=2 GeV/c and increases to approximately 4-5 at p(T) approximately 4 GeV/c. At larger p(T), the suppression remains constant within errors. The deficit is already apparent in semiperipheral reactions and increases smoothly with centrality.
Collapse
Affiliation(s)
- S S Adler
- Brookhaven National Laboratory, Upton, New York 11973-5000, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
159
|
Kim JS, Kim SG, Choi IJ, Park MJ, Kim BG, Jung HC, Song IS. Effect of Helicobacter pylori eradication on duodenal ulcer scar in patients with no clinical history of duodenal ulcer. Aliment Pharmacol Ther 2002; 16:275-80. [PMID: 11860410 DOI: 10.1046/j.1365-2036.2002.01174.x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
BACKGROUND Helicobacter pylori eradication has become the standard treatment for duodenal ulcer. However, there is no relevant evidence for antibacterial treatment of the white scar stage of duodenal ulcer (duodenal ulcer scar) in patients with no past history of duodenal ulcer. AIM To investigate whether H. pylori eradication could decrease duodenal ulcer recurrence in patients with duodenal ulcer scar and no past history of duodenal ulcer. PATIENTS AND METHODS We prospectively enrolled 66 patients with duodenal ulcer scar: 53 were H. pylori-positive and 13 were H. pylori-negative. H. pylori-positive patients were randomly assigned into two groups (two-to-one allocation): 36 patients were assigned to the treatment group and 17 to the follow-up group. Thirteen H. pylori-negative patients were followed up according to the study protocol. Follow-up endoscopy was performed to evaluate ulcer scar changes and H. pylori status 6 weeks after anti-H. pylori treatment and then every 6 months for up to 30 months. RESULTS Active duodenal ulcer recurrence was identified in seven of 23 H. pylori-positive/non-cured patients (30%). There was no duodenal ulcer recurrence in 43 H. pylori-negative/cured patients (0%), which was significantly different in terms of duodenal ulcer recurrence (P=0.001). CONCLUSIONS H. pylori eradication is effective at preventing active duodenal ulcer recurrence in patients with duodenal ulcer scar and no past history of duodenal ulcer.
Collapse
Affiliation(s)
- J S Kim
- Department of Internal Medicine, Liver Research Institute, Seoul National University College of Medicine, 28 Yongon-dong, Chongnu-gu, 110-744 Seoul, South Korea
| | | | | | | | | | | | | |
Collapse
|
160
|
Choi IJ, Jung HC, Choi KW, Kim JH, Ahn DS, Yang US, Rew JS, Lee SI, Rhee JC, Chung IS, Chung JM, Hong WS. Efficacy of low-dose clarithromycin triple therapy and tinidazole-containing triple therapy for Helicobacter pylori eradication. Aliment Pharmacol Ther 2002; 16:145-51. [PMID: 11856089 DOI: 10.1046/j.1365-2036.2002.01130.x] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
BACKGROUND Proton pump inhibitor-based triple therapies are recommended as the first-line treatment for Helicobacter pylori eradication. AIM To evaluate the efficacies of low-dose clarithromycin triple therapy and tinidazole-containing triple therapy in a metronidazole resistance prevalent area and to compare the efficacies with standard triple therapy. METHODS In a randomized, multicentre, prospective study, a total of 352 patients with duodenal ulcer or non-ulcer dyspepsia were randomly divided into three groups according to the administered regimen: OAC250 group (omeprazole, 20 mg, amoxicillin, 1000 mg, and clarithromycin, 250 mg), OAC500 group (omeprazole, 20 mg, amoxicillin, 1000 mg, and clarithromycin, 500 mg) and OTC group (omeprazole, 20 mg, tinidazole, 500 mg, and clarithromycin, 500 mg). The three groups received each regimen twice daily for 7 days. Upper gastrointestinal endoscopy was performed before and 4 weeks after treatment. H. pylori status was determined by rapid urease test and 13C urea breath test. RESULTS The eradication rates in the OAC250, OAC500 and OTC groups were 76.2%, 65.7% and 64.8% (95% confidence interval: 67.9-84.4%, 56.7-74.8% and 55.7-73.9%), respectively, by intention-to-treat analysis (P=0.149) and 92.8%, 87.2% and 84.1% (95% confidence interval: 84.4-97.3%, 77.9-93.8% and 73.9-91.2%), respectively, by per protocol analysis (P=0.088). All regimens were well tolerated and compliance was excellent. CONCLUSIONS Both low-dose clarithromycin triple therapy and tinidazole-containing triple therapy are effective and safe regimens for H. pylori eradication.
Collapse
Affiliation(s)
- I J Choi
- Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Clinical Research Institute, Seoul National University Hospital, Seoul, South Korea
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
161
|
Abstract
To evaluate the distribution and changing patterns of renal diseases in Korea, a total of 4,514 cases of renal biopsy collected over a 23-year period between 1973 and 1995 were reviewed. Of 4,200 cases excluding 314 unsatisfactory biopsies, adult cases comprised 59.5% and pediatric cases, 40.5%. The male to female ratio was 1.5:1 in adults and 2.2:1 in children. Glomerulonephritis (GN) comprised 80.0% of the total. The most common primary GN in adults was minimal change disease (MCD) (26.6%), followed by IgA nephropathy (IgAN) (22.1%), membranous GN (MGN) (11.8%), and membranoproliferative GN (MPGN) (5.9%). In children, the primary GN incidence rates were MCD (24.8%), IgAN (10.3%), poststreptococcal (including postinfectious) GN (PSGN) (8.6%), and focal segmental glomerulosclerosis (FSGS) (4.0%). The most common secondary GN in adults was lupus nephritis and in children Henoch-Schonlein purpura nephritis. The most common cause of nephrotic syndrome was MCD in both adults and children, followed by MGN and FSGS. The elderly, aged sixty years and older, comprised 2.7% of cases and recorded equal numbers of MCD and MGN. The proportion of the biopsies found to be seropositive for HBs antigen was 27.9%, and these showed either MGN or MPGN pattern. Repeat biopsy was performed in 168 patients, due to previous biopsy failure in 15.5%. When the primary GN cases were analyzed at 5-year intervals, the prevalence of PSGN, which was greater than 25% during the 1973-1982 period, decreased abruptly in children thereafter, whereas the prevalence of FSGS increased slowly since the 1988-1992 period in both adults and children. The decrease of PSGN and the increase of FSGS suggest a role for socioeconomic and environmental factors in Korea.
Collapse
Affiliation(s)
- I J Choi
- Department of Pathology, College of Medicine and the Institute of Kidney Disease, Yonsei University, Seoul, Korea
| | | | | | | | | | | | | | | | | |
Collapse
|
162
|
Kim HC, Kim DK, Choi IJ, Kang KH, Yi SD, Park J, Park YN. Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population. Psychiatry Clin Neurosci 2001; 55:115-20. [PMID: 11285089 DOI: 10.1046/j.1440-1819.2001.00797.x] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
The gene for human apolipoprotein E (APOE) is found on the long arm of chromosome 19 (19q13.2) and exists in three common allelic forms, epsilon2, epsilon3, and epsilon4. The APOE epsilon4 allele is overrepresented in Alzheimer's disease (AD) and is accepted as a genetic risk factor. Some studies reported a protective effect of the APOE epsilon2 allele for AD. However, there are some ethnic variations in the proportion of different APOE alleles and their relationship to AD. We examine the distribution of APOE alleles from 30 AD patients and 158 controls in Korea. The control subjects were all cognitively intact unrelated Koreans. The frequencies of APOE alleles in AD patients were 18.3% (epsilon2), 58.3% (epsilon3), and 23.3% (epsilon4). The corresponding frequencies in controls were 13.3% (epsilon2), 72.5% (epsilon3), and 14.2% (epsilon4). The frequency of the APOE epsilon2 allele in AD patients was not significantly different from that in controls. When statistical analysis was conducted after the exclusion of the APOE epsilon2 allele, the frequency of the APOE epsilon4 allele in AD patients was significantly higher than that in controls (P < 0.05). These results support that the APOE epsilon4 allele plays a role as a risk factor for AD in Koreans and suggest that the APOE epsilon2 allele may not play a protective role in the development of AD in Koreans.
Collapse
Affiliation(s)
- H C Kim
- Department of Psychiatry, Institute for Medical Genetics, Keimyung University School of Medicine, Korea.
| | | | | | | | | | | | | |
Collapse
|
163
|
Jeong HJ, Kim JH, Kim PK, Choi IJ. Glomerular growth under cyclosporine treatment in childhood nephrotic syndrome. Clin Nephrol 2001; 55:289-96. [PMID: 11334314] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/19/2023] Open
Abstract
BACKGROUND Glomerular hypertrophy is important in children with idiopathic nephrotic syndrome in regard to diagnosis and pathogenesis. Moreover, glomerular growth may be altered by cyclosporine (CsA) treatment in these patients. METHODS Bowman's area (BA) and the glomerular tuft area (GA) of pre- and post-treatment biopsies was measured by morphometry in 47 children with idiopathic nephrotic syndrome (39 MCD and 8 FSGS) treated with CsA and low-dose prednisolone for up to 2 years. RESULTS BA and GA increased with age. The mean BA and GA were 1.2 times larger in FSGS than in MCD and the proportional increase was similar in both diseases after treatment. BA and GA decreased in 48.9% and 40.4% of cases after treatment, respectively, whereas tubulointerstitial lesion (TIL) developed in 27.7%. BA and GA decreased to 10.4% and 8.3%, respectively in children who developed TIL after treatment and the values were largely unchanged in those treated for more than 16 months. CONCLUSIONS Glomerular growth is hampered by CsA nephrotoxicity, which is a more common complication than TIL. The impairment of glomerular growth is related to the duration of treatment and the development of TIL, but not to age or diagnosis.
Collapse
Affiliation(s)
- H J Jeong
- Department of Pathology, Yonsei University College of Medicine, Seoul, Korea.
| | | | | | | |
Collapse
|
164
|
Abstract
Oculocutaneous albinism is an autosomal recessive genetic disorder. Several types of oculocutaneous albinism are caused by mutation in related genes. Oculocutaneous albinism 1 is associated with the tyrosinase gene. The human tyrosinase gene (TYR) encodes tyrosinase, a key enzyme in melanin biosynthesis. As exon 1 of the gene shows an MboI-RFLP within codon 192 in Caucasians, we studied allele frequencies of MboI 192 polymorphism in 200 chromosomes from 100 unrelated normal Korean individuals. As a result, only one allele system, the presence of the MboI 192 site, was detected in the Korean.
Collapse
Affiliation(s)
- D K Kim
- Department of Anatomy, School of Medicine, Keimyung University, Dongsan-Dong, Jung-Gu, Taegu 700-712, South Korea.
| | | | | |
Collapse
|
165
|
Kim JS, Lim SH, Choi IJ, Moon H, Jung HC, Song IS, Kim CY. Prediction of the clinical course of Behçet's colitis according to macroscopic classification by colonoscopy. Endoscopy 2000; 32:635-40. [PMID: 10935793 DOI: 10.1055/s-2000-9012] [Citation(s) in RCA: 42] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
BACKGROUND AND STUDY AIMS The lesions in Behçet's colitis show aphthoid or punched-out ulceration, but the macroscopic types of lesion found have not been defined. To predict the clinical outcome in patients with Behçet's colitis according to the colonoscopic findings, we classified the characteristic colonic ulcers, evaluated the efficacy of medical treatment on colonoscopic lesions, and calculated the operation rates and recurrence rates relative to the macroscopic types. PATIENTS AND METHODS The medical records and colonoscopic photographs of 50 patients with Behçet's colitis were reviewed. The colonic lesions were examined by colonoscopy in patients with Behçet's disease and gastrointestinal symptoms. The colonoscopic findings were categorized into three types of ulceration: volcano-like, geographic, and aphthous. The efficacy of medical treatment was assessed by follow-up colonoscopy or double-contrast barium enema four to eight weeks after treatment, and recurrence of the lesions was evaluated during the follow-up periods. Cumulative surgery rates were obtained using the Kaplan-Meier method. RESULTS The macroscopic classification of colonic ulcers identified 25 of 50 patients (50%) with volcano-type lesions, 11 (22%) with the geographic type, and 14 (28%) with the aphthous type. The rates of complete remission after medical treatment and surgery, respectively, were six of 25 (24%) and 13 of 25 (52%) with volcano-type ulcerations; eight of 11 (73%) and one of 11 (9%) with the geographic type; and nine of 14 (64%) and two of 14 (14%) with the aphthous type. The endoscopic and clinical recurrence rates were nine of 19 (47%) in volcano-type ulcerations, one of nine (11%) in the geographic type, and one of 11 (9%) in the aphthous type. CONCLUSION Volcano-type ulcerations in Behçet's colitis showed a less favorable response to medical treatment, a more frequent requirement for surgery, and more frequent recurrences than the geographic and aphthous types of ulcerations.
Collapse
Affiliation(s)
- J S Kim
- Dept. of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Korea
| | | | | | | | | | | | | |
Collapse
|
166
|
Abstract
PURPOSE The present study was aimed at evaluating the long-term course of intestinal Behçet's disease and determining predictive factors of prognosis. METHODS This report is a retrospective study based on the records of 43 patients with intestinal Behçet's disease. The mean follow-up duration was 73 +/- 60 months. We evaluated the efficacy of medical treatment for the intestinal lesion at initial eight weeks. The cumulative probabilities were calculated by using Kaplan-Meier method, and the results were compared by using the log-rank test. RESULTS Sixteen patients (38 percent) achieved a complete remission of intestinal lesions eight weeks after medical treatment had begun. The patients who achieved a complete remission had a lower probability of receiving an operation than those who had not (13 percent at 2 and 5 years vs. 36 and 43 percent, respectively; P = 0.028). The recurrence probability of intestinal lesions was 25 percent at two years and 49 percent at five years after complete remission with medical treatment. Patients who had a history of intestinal perforation or fistula had a higher probability of recurrence after operation than those without such history (59 vs. 33 percent at 2 years; 88 vs. 57 percent at 5 years; P = 0.020). Patients who had taken azathioprine had a lower probability of receiving reoperation than those who did not (7 vs. 25 percent at 2 years; 25 vs. 47 percent at 5 years; P = 0.035). The length of ileal resection and whether hemicolectomy was performed had no significant effect on the recurrence or reoperation rate. CONCLUSIONS Intestinal Behçet's disease frequently requires a surgical treatment and has a high recurrence rate. The patients who achieved a complete remission with medical treatment, who had no history of intestinal perforation, and who received azathioprine after operation showed better clinical courses. Resection of a short segment of bowel would be a more appropriate surgical procedure.
Collapse
Affiliation(s)
- I J Choi
- Department of Internal Medicine, Seoul National University College of Medicine, Korea
| | | | | | | | | | | | | |
Collapse
|
167
|
Riley LB, Lange MK, Browne RJ, Cochrane PJ, Choi IJ, Davis B, Arcona S, Alhadeff JA. Analysis of cathepsin D in human breast cancer: usefulness of the processed 31 kDa active form of the enzyme as a prognostic indicator in node-negative and node-positive patients. Breast Cancer Res Treat 2000; 60:173-9. [PMID: 10845280 DOI: 10.1023/a:1006394401199] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
The relative amounts of the precursor (52 kDa) and processed (31,27 kDa) forms of cathepsin D have been analyzed by Western blotting in biopsied breast tissue cytosols from 134 lesions from invasive breast cancer patients, 24 lesions from patients with ductal carcinoma in situ (DCIS), 227 lesions from benign breast disease patients, and 28 lesions from normal control subjects. The mean relative percentage amount of the 31 kDa form was significantly increased (p < 0.001) in the invasive breast cancer group compared to the other three groups. In addition, the mean relative percentage amount of the 31 kDa form was significantly increased (p < 0.05) in node-positive compared to node-negative breast cancer patients. In the benign breast disease group, patients with proliferative-type disease had a significantly increased (p = 0.02) mean relative percentage amount of the 31 kDa form of cathepsin D compared to patients with nonproliferative-type disease. Invasive breast cancer patients were followed for up to 75 months to determine if the relative percentage amount of the 31 kDa form of cathepsin D was predictive of disease-free and overall survival. Although the amount of the 31 kDa form was not predictive of disease-free survival, patients in the 'high' 31 kDa group (> 18%) were significantly (p < 0.05) more likely to die than patients in the 'low' 31 kDa group (< or = 18%). The 12 patients who died were all node-positive and in the high 31 kDa group. It thus appears that the relative amount of the processed, active 31 kDa form of cathepsin D is a useful prognostic indicator, at least in node-positive breast cancer patients.
Collapse
Affiliation(s)
- L B Riley
- Department of Surgery, St. Luke's Hospital and Health Network, Bethlehem, PA, USA
| | | | | | | | | | | | | | | |
Collapse
|
168
|
Abstract
Twenty-nine children with nephrotic syndrome were treated with cyclosporine (CsA), 100 mg/m2/day for 6 months and prednisone, 2 mg/kg every other day for 1 month and then subsequently 1 mg/kg every other day for 5 months. A renal biopsy had shown minimal change disease (MCD) in 18 children, focal segmental glomerulosclerosis (FSGS) in 3 children, membranous glomerulonephritis (MGN) in 4 children, membranoproliferative glomerulonephritis (MPGN) in 2 children, and IgA nephropathy in 2 children. All MCD patients went into complete remission during therapy. Five out of 11 steroid-sensitive patients (45.5%) remained in complete remission, while the remaining 6 (54.5%) had 2 to 3 relapses, 19 to 47 months after CsA discontinuation. Two out of 7 steroid-resistant patients (28.6%) were still in complete remission and 5 (71.4%) had 1 to 6 relapses 25 to 49 months after CsA withdrawal. The mean number of relapses in the steroid-sensitive group before and after CsA treatment decreased more (8.5 vs 1.4) than in the steroid-resistant group (8.1 vs 2.4) (p < 0.05). At the most recent examination, 1 of 3 FSGS patients achieved complete remission and 2 had a partial response. Three of 4 MGN patients were in complete remission and 1 was in partial remission. One of 2 MPGN patients achieved complete remission and 1 showed partial remission. Two patients with IgA nephropathy were in partial remission. We compared MCD patients in sustained remission and relapse; the mean CD4/CD8 ratio decreased from 1.5 to 0.9 in the remission group, in comparison with no change in the relapsed group (p < 0.05). The posttreatment renal biopsy showed lesions of nephrotoxicity in 3 of 18 children with MCD whose renal function did not alter after CsA treatment. We concluded: 1) A 6-month treatment of CsA, in combination with a low-dose alternate-day steroid, proved to be effective in maintaining the remission of steroid-sensitive and steroid-resistant MCD patients. 2) The CD4/CD8 ratio can be used as a index to predict remission or relapse after CsA therapy.
Collapse
Affiliation(s)
- P K Kim
- Department of Pediatrics, Yonsei University College of Medicine, Seoul, Korea
| | | | | | | | | |
Collapse
|
169
|
Lee HS, Kim JS, Choi IJ, Chung JW, Park JH, Kim CY. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study. Cancer 1997. [PMID: 9179054 DOI: 10.1002/(sici)1097-0142(19970601)79:11<2087::aid-cncr5>3.0.co;2-m] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
BACKGROUND Transcatheter arterial chemoembolization (TACE) has been contra-indicated for the treatment of patients with hepatocellular carcinoma (HCC) and main portal vein (MPV) obstruction because of the potential risk of hepatic insufficiency resulting from ischemia after TACE. The current controlled study was undertaken to assess the safety, efficacy, and predictive factors of favorable response to TACE in patients with HCC and MPV obstruction with good hepatic function and adequate collateral circulation around the MPV. METHODS Of a total of 47 patients, 31 were treated with TACE, and 16 who declined the procedures were untreated controls. Thirty-six patients (77%) had diffuse-type HCC and 11 (23%) had nodular-type HCC. During the first week after TACE immediate postprocedural complications were evaluated, and the development of hepatic insufficiency as a late complication was assessed at the end of the fourth week. The cumulative survival rate was estimated by the Kaplan-Meier method, and predictors of better prognosis were obtained by univariate and multivariate analyses. RESULTS Although no patients showed clinical evidence of hepatic insufficiency as an immediate complication, transient fever and abdominal pain were common. Progressive hepatic insufficiency developed at the fourth week; however, there was no difference between the treated and untreated groups. The survival time of treated patients was statistically no longer than that of untreated patients. In the univariate analysis, tumor type and size, the pattern of iodized oil uptake in the tumor, and the presence of iodized oil uptake in the tumor thrombi at the MPV significantly influenced the prognosis. Tumor type, whether treated or not, was the most important prognostic factor patients with nodular-type HCC had significantly longer survival time (median, 11 months) than those with diffuse-type HCC (median, 4 months). Regarding the efficacy of TACE, there was no statistical difference in survival between treated and untreated diffuse-type HCC patients. In comparison, with nodular-type HCC it seemed that survival time was longer for TACE-treated patients (median, 30 months) than for untreated patients (median, 7 months). CONCLUSIONS TACE may be a safe modality for the treatment of patients with HCC and MPV obstruction, provided that the patients have good hepatic function and collateral circulation around the MPV. However, TACE was not efficacious in the treatment of diffuse-type HCC. The authors recommend TACE for treating nodular-type HCC because of the potential benefit of prolonged survival.
Collapse
Affiliation(s)
- H S Lee
- Department of Internal Medicine, Seoul National University Collage of Medicine, South Korea
| | | | | | | | | | | |
Collapse
|
170
|
Abstract
The serous cystadenoma of the pancreas is a rare lesion that is usually found incidentally. It is mostly observed as a spongy microcystic mass but rare variants such as macrocystic, unicystic, or multicentric are also seen. We recently experienced a unique case of unicystic serous cystadenoma mimicking a pseudocyst. It was grossly a unilocular cyst with surrounding dense fibrosis resembling a pseudocyst. Microscopically, the cyst was partly lined by low columnar-to-cuboidal cells with clear cytoplasm containing glycogen.
Collapse
Affiliation(s)
- Y M Jin
- Department of Pathology, School of Medicine, Ajou University, Paldal-gu, Suwon, Korea
| | | | | |
Collapse
|
171
|
Jeong HJ, Hong SW, Kim YS, Kim MS, Choi IH, Park K, Choi IJ. Interstitial mononuclear cell infiltrates in chronic rejection of the kidney and correlation with peripheral blood. J Korean Med Sci 1996; 11:489-94. [PMID: 9008097 PMCID: PMC3054262 DOI: 10.3346/jkms.1996.11.6.489] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
Abstract
To investigate the characteristics of interstitial inflammatory cells and possible involvement of nudelta T cells, 16 renal allograft biopsies showing chronic rejection were stained by immunohistochemical method and correlated with the data of peripheral blood evaluated by flow cytometry. For immunophenotyping, fresh frozen sections were stained with monoclonal antibodies against CD3, CD4, CD8, CD68, CD56, TCRdelta1 and HLA DR. Paraffin embedded tissue was stained with CD45RO, CD20-Cy and CD68. Nine cases of nonspecific tubulointerstitial change and 4 cases of nonallograft tubulointerstitial nephritis were used as a control. Inflammatory infiltration was present in all cases studied. T cells predominated in the interstitium of chronic rejection and were followed by macrophages and B cells. The degree of interstitial infiltration of frozen section was not accordant with that of paraffin sections. Allografts with nonspecific tubulointerstitial changes or tubulointerstitial nephritis of native kidneys showed similar distribution pattern in terms of type and degree. However, the degree of infiltrate did not give any statistical significance among groups. The CD4/CD8 ratios in interstitial infiltrates were less than 1.0 in 6 cases and was not accordant with those of peripheral blood. Proportion of nudelta T cells increased over 10% in 2 cases in tissue and in 3 cases in peripheral blood. In 3 cases of chronic rejection in which both tissue and blood results were available, there was no concordance of CD4/CD8 or nudeltaT/CD3 between them. Tubular expression of HLA DR was, however, present only in 4 cases of chronic rejection. In conclusion, T lymphocytes were predominant regardless of diagnosis or disease activity. T lymphocyte subset did not give any suggestion as to the diagnosis or disease activity in chronic rejection. Furthermore nudelta T cells had only limited value. Lymphocytic subsets in peripheral blood would not be predictors of tissue destruction in chronic rejection.
Collapse
Affiliation(s)
- H J Jeong
- Department of Pathology, Yonsei University College of Medicine, The Institute of Kidney Disease, Seoul, Korea
| | | | | | | | | | | | | |
Collapse
|
172
|
Jeong HJ, Kim YS, Oh CK, Park K, Choi IJ. Immunologic and nonimmunologic contributors to glomerular segmental sclerosis in renal transplantation. Transplant Proc 1996; 28:1224-5. [PMID: 8658635] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Affiliation(s)
- H J Jeong
- Department of Pathology, College of Medicine, Yonsei University, Seoul, Korea
| | | | | | | | | |
Collapse
|
173
|
Abstract
A retrospective study of 223 patients with IgA nephropathy (IgAN) was performed to clarify the prognostic factors and the renal survival rates of the disease. One hundred twenty-two patients were followed-up for more than 6 months after their renal biopsy (mean follow-up duration: 43.0 months), and 20 of them (16.4%) had progressed to end-stage renal disease (ESRD). Using univariate analysis, 8 risk factors (2 clinical and 6 histopathological findings) for developing ESRD were identified: renal insufficiency at initial presentation (serum creatinine > or = 1.5 mg/dl); heavy proteinuria (> or = 3.5 gm/day); moderate to severe histopathologic findings such as class IV/V lesions by W.H.O. classification, mesangial hypercellularity, glomerular sclerosis, interstitial infiltration, interstitial fibrosis, and tubular atrophy. In multivariate regression analysis, class IV/V lesions and renal insufficiency at initial presentation were the independent prognostic factors of IgAN. The renal survival rates were 100% at 1 year, 97.0% at 3 years, and 78.9% at 5 years. In conclusion, it seems that about 20% of IgAN patients have a risk to progress to ESRD within 5 years, and a careful follow-up is recommended especially in patients who have either renal insufficiency at the time of presentation or severe renal pathology (class IV/V lesions).
Collapse
Affiliation(s)
- S W Kang
- Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
| | | | | | | | | | | | | | | | | |
Collapse
|
174
|
Jeong HJ, Kim YS, Oh CK, Park K, Choi IJ. Proteinuria after renal allograft: assessment based on severity and causes. Transplant Proc 1994; 26:2132-3. [PMID: 8066695] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Affiliation(s)
- H J Jeong
- Department of Pathology, Yonsei University College of Medicine, Seoul, Korea
| | | | | | | | | |
Collapse
|
175
|
Chung SS, Kim SH, Yang WI, Choi IJ, Lee WY, Moon JG, Park HS, Shin HS, Kim DS, Ahn YM. Homogenous fetal dopaminergic cell transplantation in rat striatum by cell suspension methods. Yonsei Med J 1993; 34:145-51. [PMID: 8379193 DOI: 10.3349/ymj.1993.34.2.145] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/30/2023] Open
Abstract
The transplantation of dopaminergic neurons in the brain has been attempted in experimental animals and humans as the new treatment modality of Parkinson's disease. Before the trial of dopaminergic neuronal transplantation in human, the authors proceeded with the animal experiment of fetal dopaminergic cell transplantation in a rat Parkinson's disease model. The aims of this experiment were to confirm the availability of fetal mesencephalic cells as the donor, to compare the viability of cells according to different cell manipulation methods, and to follow up the functional recovery in the transplanted Parkinson's disease model. As a result, the authors concluded that the simple enzyme digestion method had a better cell survival rate than the multiple enzyme digestion method. Also, the transplanted mesencephalic cells could not only survive in the host animal but also promote functional recovery.
Collapse
Affiliation(s)
- S S Chung
- Department of Neurosurgery, Yonsei University College of Medicine, Seoul, Korea
| | | | | | | | | | | | | | | | | | | |
Collapse
|
176
|
Abstract
Twenty-five cases of minimal change nephrotic syndrome(minimal change disease, MCD) with mesangial IgA deposition were evaluated electron microscopically. The thickness of the glomerular basement membrane(GBM) was 3875 +/- 1271 A and 3056 +/- 1201 A in adults and children, respectively. Alteration of the GBM was noted in 3 adults and eight children: splitting in 4, focal thinning in one, widening of the lamina rara interna in 10, and widening of the lamina rara externa in 4 cases. Minimal mesangial electron dense deposits were found in all but one adult, and an increase of the mesangial matrix and minimal mesangial proliferation were observed in 8 and 6 cases, respectively. Electron microscopic findings show representative findings of MCD in our cases. A relationship between the GBM alterations in these cases and frequent association of hematuria is suggested and discussed.
Collapse
Affiliation(s)
- H J Jeong
- Department of Pathology, Yonsei University College of Medicine, Seoul, Korea
| | | | | |
Collapse
|
177
|
Abstract
Flow cytometric DNA analysis was performed on 19 adrenal pheochromocytomas and 6 extra-adrenal paragangliomas in parallel with clinical and histopathological review to determine the usefulness of this technique to predict biologic behavior of these tumors. In pheochromocytomas and paragangliomas, tetraploidy or near-tetraploidy occurred in 32% and 33% and aneuploidy in 10% and none respectively. A case of malignant pheochromocytoma had diploid DNA content. Occurrence of aneuploidy or tetraploidy is frequent in clinically benign tumors in conjunction with a marked degree of nuclear atypia and cannot be a predictor of malignancy.
Collapse
Affiliation(s)
- W H Jung
- Department of Pathology, Yonsei University College of Medicine, Seoul, Korea
| | | | | | | |
Collapse
|
178
|
Roh JK, Paik S, Chung HC, Yang W, Kim HK, Choi IJ, Kim J, Koh E, Lee KS, Min JS. Overexpression of erbB-2 protein in gastric adenocarcinoma--a potential role in therapeutic response to adjuvant 5-FU-doxorubicin regimen. Gan To Kagaku Ryoho 1992; 19:1207-19. [PMID: 1355336] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/25/2023]
Abstract
In order to study the influence of erbB-2 protein overexpression on outcome of patients with gastric cancer after attempted curative resection with or without adjuvant chemotherapy, paraffin embedded sections from 109 cases of primary gastric cancer with defined treatments have been immunostained for erbB-2 protein in a retrospective study. Thirty four cases (31%) showed strong membrane staining of tumor cells. erbB-2 overexpression did not show significant effect on outcome when all patients were considered. However, erbB-2 overexpression was an indicator for poor disease free survival (p = 0.0474), local relapse free survival (p = 0.0293), and overall survival (p = 0.0310) of the patients treated with surgery only (N = 51), while it did not show any effect on outcome of patients treated with 5-FU plus Doxorubicin (FA) as adjuvant chemotherapy (N = 58). Furthermore, the apparent therapeutic benefit from FA regimen was restricted to patients with erbB-2 positive tumors. Combined predictive value of erbB-2 and FA regimen was found to be significant in predicting local relapse in multivariate analysis (p = 0.0439). The data suggests that erbB-2 may be associated with an improved response to FA regimen and that erbB-2 should be included as a potential confounding variable in the analysis of the data from the clinical trials for gastric cancer.
Collapse
Affiliation(s)
- J K Roh
- Yonsei Cancer Center Surgery, and Microbiology, Seoul, Korea
| | | | | | | | | | | | | | | | | | | |
Collapse
|
179
|
Abstract
Subacute necrotizing lymphadenitis (SNL) is a well documented and unique clinicopathologic entity, although its etiology and pathogenesis have not been clearly established. Microscopically, cortical and paracortical necrotizing lesions with karyorrhexis, abundant nuclear debris and infiltration of large mononuclear cells are characteristic. This study analyzed the common clinical and pathological features of 118 patients with SNL and the nature of the mononuclear cells. Patients were generally young women and revealed cervical lymphadenopathy with tenderness, fever, leukopenia and elevation of the erythrocyte sedimentation rate. Features of the adjacent uninvolved area in the lymph node included a starry sky pattern, follicle centers, sinus histiocytosis or aggregation of foamy histicoytes. There was an inverse relationship between the extent of necrosis and of histocytic infiltration but not between the extent of necrosis and the duration from the onset of symptoms to the diagnosis. Immunohistochemically the infiltrated mononuclear cells of the affected foci were T lymphocytes and histiocytes. The clinical, histological and immunohistochemical features suggest that SNL represents a hypersensitivity reaction to certain infectious agent without forming granuloma.
Collapse
Affiliation(s)
- K H Kim
- Department of Pathology, Yonsei University College of Medicine, Seoul, Korea
| | | | | | | |
Collapse
|
180
|
Abstract
Paraffin embedded sections of 64 breast carcinomas were stained immunohistochemically using a commercially available monoclonal antibody to estrogen receptor. To improve the sensitivity of the staining, the authors used a Pronase enzyme pretreatment, biotinylated antibody to rat IgG as secondary antibody, streptavidin-alkaline phosphatase as tertiary reagent and fast red as chromogen. When compared to the results of estrogen receptor enzyme immunoassay, this method yielded an 85.9% concordance rate, 86.2% specificity and 85.7% sensitivity. When compared to estrogen receptor immunocytochemistry(ER-ICA) in frozen section and considering the inherent advantages of immunohistochemical staining over biochemical assay, the major advantages of this method are good morphology, suitability for retrospective study and reduced cost of staining due to dilution of expensive primary antibody. Thus, this method offers an alternative to ER assay using fresh tissue and should provide additional valuable information about estrogen receptor.
Collapse
Affiliation(s)
- W I Yang
- Department of Pathology, Yonsei University College of Medicine, Seoul, Korea
| | | | | | | |
Collapse
|
181
|
Abstract
A case of adenoid cystic carcinoma of the prostate gland in a 38-year-old Korean man is described. Microscopically, variable patterns, that is, glandular, trabecular, cribriform and solid areas, were seen. The unusual location of this tumor in our patient highlights the ubiquitous distribution of this malignant neoplasm.
Collapse
Affiliation(s)
- S K Ahn
- Department of Pathology, Yonsei University College of Medicine, Seoul, Korea
| | | | | | | |
Collapse
|
182
|
Abstract
To evaluate the distribution pattern of renal diseases based on needle biopsy, we analyzed 2361 cases of renal biopsy and necropsy material examined at the Department of Pathology from 1973 to 1988. The average age was 21.1 years for males and 23.7 years for females. The adult cases comprised 60.2% and the child cases 39.8%. The male to female ratio was 1.6: 1 in adults and 2.3:1 in children. Glomerular diseases were 97.8% of the total; primary glomerulonephritis (GN) 59.8% and secondary GN 27.6% The major glomerular diseases, in descending order of frequency, were; minimal change nephrotic syndrome (MCNS; 24.2%), IgA nephropathy (IgAN; 17.8%), benign recurrent hematuria (BRH; 8.8%), membranous GN (MGN; 7.9%), acute poststreptococcal GN (APSGN; 7.3%), mesangioproliferative GN (MspGN; 5.5%), minimal mesangiopathy (5.5%), membranoproliferative GN(4.1%), and focal segmental glomerulosclerosis (FSGS; 2.7%). GN of systemic disease included 77 cases of lupus nephritis, 157 cases of Henoch-Schönlein purpura nephritis (HSPN) and 7 cases of systemic infection excluding Hepatitis B viral hepatitis. The most common glomerular diseases were MCNS, IgAN, MGN and MspGN in adults, and MCNS, BRH, HSP-N and APSGN in children. HBs antigenemia was found in 71 cases, of which MGN and IgAN were the most frequent. HBs antigenemia-associated MGN was prevalent in male children, whereas IgAN was prevalent in adults.(ABSTRACT TRUNCATED AT 250 WORDS)
Collapse
Affiliation(s)
- I J Choi
- Department of Pathology, Yonsei University College of Medicine, Seoul, Korea
| | | | | | | | | | | |
Collapse
|
183
|
Abstract
This study reviewed 65 cases of polymorphic reticulosis (PR) with respect to clinical and histopathologic bases, and immunohistochemical studies were done using MT1 and UCHL as T-cell markers, MB2 as a B-cell marker and alpha-1-antichymotrypsin as a histiocytic marker. The results obtained were as follows: 1. The male to female ratio was 2.4:1 and the mean age of patients was 44.5 years. The sites involved primarily were the nasal cavity, tonsil and pharynx and about one-fourth of the total cases showed extensive involvement of two anatomical sites at initial presentation. 2. Almost all cases showed characteristic histologic features similar to those of peripheral T-cell lymphoma and showed positive reaction to the T-cell marker. The above immunohistochemical findings suggest strongly that quite a significant portion of PR is in fact T-cell lymphoma.
Collapse
Affiliation(s)
- Y N Park
- Department of Pathology, Yonsei University College of Medicine, Seoul, Korea
| | | | | | | |
Collapse
|
184
|
Yang WI, Jung SH, Choi IJ. Non-Hodgkin's lymphoma: a histopathologic and immunohistochemical study of 79 cases. Yonsei Med J 1990; 31:123-33. [PMID: 2219970 DOI: 10.3349/ymj.1990.31.2.123] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/30/2022] Open
Abstract
Recently immunophenotyping has become a valuable tool in the diagnostic workup of malignant lymphoma. We classified 79 consecutive cases of non-Hodgkin's lymphoma experienced at our hospital during the last two years according to the Working Formulation and immunologically using MT1, UCHL1 and MB2 monoclonal antibodies. The results of this study are as follows: 1) four cases (5.1%) were low grade, 54 cases (68.4%) were intermediate grade, and 21 cases (23.3%) were high grade. The most common subtype was 'diffuse, mixed' type, 2) fifty cases (63.3%) showed T-cell phenotype and 14 cases (17.7%) showed B-cell phenotype. Immunophenotyping was impossible in 15 cases due to either double staining or negative staining. 3) the incidence of extranodal presentation was high (65.8%) and the most common extranodal site was the upper aerodigestive tract (29.1%) followed by the gastrointestinal tract (16.4%), and 4) MT1, UCHL1 and MB2 monoclonal antibodies are valuable markers of T- and B-cells in paraffin embedded tissue, enabling retrospective study. However, because these antibodies are not lineage specific, the results of immunostaining should be interpreted with caution.
Collapse
Affiliation(s)
- W I Yang
- Department of Pathology, Yonsei University College of Medicine, Seoul, Korea
| | | | | |
Collapse
|
185
|
Abstract
Fibrocystic disease of the breast has been generally regarded as a disorder due to either excess hormonal stimulation or an exaggerated proliferative response by hypersensitive breast epithelium. The unique lobular lesion-adenosis- and its variants have been regarded as non-neoplastic and non-preneoplastic glandular hypertrophy and hyperplasia, and have different organoid patterns and origins. We have examined a total of 242 cases previously diagnosed as 'fibrocystic disease' at the Department of Pathology with the purpose of clarifying the variants of adenosis in detail and refining the infinitely large 'fibrocystic disease' classification as non-proliferative fibrocystic change and proliferative disorders, such as epitheliosis and atypical hyperplasia. In this study, 224 cases (92.5%) were nonproliferative disease, mostly adenosis (40.1%), and 18 cases (7.5%) were proliferative disease, which consisted of moderate to florid hyperplasia and epitheliosis.
Collapse
Affiliation(s)
- H J Ahn
- Department of Pathology, Dong Suwon Hospital, Kyongido, Korea
| | | | | | | |
Collapse
|
186
|
Abstract
Mesangial IgA nephropathy was experimentally induced in ddY mice by oral and parenteral administration of the poliomyelitis vaccine (POLIO), and we then tried to investigate if IgA deposition could be prevented by the concurrent use of sodium cromoglycate (SCG), which is known to inhibit the local mucosal immune reaction. Mucosal and systemic immunity could be induced by the administration of POLIO; proteinuria, increased serum IgA levels, mesangial cell proliferation, mesangial matrix widening, mesangial deposits of IgA, and large electron dense deposits in the mesangium were observed. Concurrent administration of SCG and POLIO resulted in a significant decrease in the serum IgA level and mesangial IgA deposits. The later addition or abstinence of SCG after the 70th day did not influence the glomerular mesangial IgA deposition. But the serum IgA level was still decreased by the continuous treatment of SCG even after the 70th day. Thus, mesangial IgA nephropathy simulating IgA nephropathy in humans could be induced in ddY mice using POLIO and its induction could largely be prevented by the concurrent use of SCG. However mesangial IgA deposits already present could not be cleared by the late administration of SCG.
Collapse
Affiliation(s)
- S Y Jin
- Department of Pathology, Yonsei University, Wonju College of Medicine, Korea
| | | |
Collapse
|
187
|
Abstract
Recently we experienced a case manifested by a lump in both breast that mimicked carcinoma but was found to be a vasculitis of the giant cell type. Our case was characterized histologically by granulomatous arteritis involving small to medium sized arteries of the breast without involvement of the temporal artery. We described the clinical and pathologic features of a case of giant cell arteritis of the breast and reviewed the eight previously reported cases in foreign literature.
Collapse
Affiliation(s)
- K H Kim
- Department of Pathology, Yonsei University College of Medicine, Seoul, Korea
| | | | | |
Collapse
|
188
|
Abstract
A case of Wilms' tumor in a 67 year-old female is presented. The tumor totally replaced the left kidney with extension to Gerota's fascia, the adrenal gland and ureter, with tumor thrombi in the left renal vein. Multiple bony metastases to the skull, shoulder, rib, ilium, acetabulum and femur were noted also. Microscopically, the tumor was composed predominantly of blastemal tissue with diffuse anaplasia with areas of tubular differentiation and chondroid elements. Clear cell nests were found in the proximal ureter with gradual maturation downward.
Collapse
|
189
|
Jeong HJ, Lee MK, Choi IJ, Lee YB. Distribution of lymphocytic subpopulations infiltrated in thyroid glands of Graves' disease. Yonsei Med J 1989; 30:118-24. [PMID: 2800562 DOI: 10.3349/ymj.1989.30.2.118] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/02/2023] Open
Abstract
We studied ninety cases of thyroid glands both histopathologically and by immunohistochemical methods in patients with Graves' disease using B and T cell markers to evaluate the role of lymphocytic subpopulation. Females were affected more frequently than males with a ratio of 6.5:1, and usually the females were younger than the males at the time of surgery. The heavier the lymphocytic infiltration, the higher was the percentage of germinal center formation or fibrosis. The degree of lymphocytic infiltration was also related to the titers of antithyroglobulin or antimicrosomal antibodies. T cells were mostly scattered individually or in small groups between the follicles; however, in the severely infiltrated group, the major pattern was in clusters. T8 positive cells were more abundant than T4 positive cells, and their distribution pattern was accordant with T11 positive cells. Immunoglobulin synthesizing B cells were positively stained in 47 of 94 cases tested and IgG was the most predominant. In the mild and moderate lymphocytic infiltration groups, IgM was mostly stained at the mantle zone or in the lymphoid cluster of the interfollicular stroma, whereas IgM positive cells were present exclusively in the germinal center of the severely infiltrated group. The results of our study indicate that the major lymphocyte subpopulation in Graves' disease is B lymphocytes, and the degree of T lymphocytic infiltration correlated better with titers of antimicrosomal antibody than antithyroglobulin.
Collapse
|
190
|
Abstract
Seventy-two cases of benign fibro-osseous lesions of the jaws were reassessed, and a modified classification is proposed that may be helpful in their understanding and management. The anatomical distribution of these cases is described and compared to previously reported cases. The histogenesis of each particular lesion is also discussed. Correlative analysis of histopathologic and oral radiographic features is essential for definitive diagnosis.
Collapse
|
191
|
Choi SI, Kim KR, Jeong HJ, Park CI, Choi IJ. Histopathologic and immunocytochemical study of Hodgkin's disease. Yonsei Med J 1988; 29:326-32. [PMID: 3072781 DOI: 10.3349/ymj.1988.29.4.326] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
|
192
|
|
193
|
Choi IJ, Jeong HJ, Kim PK, Lee JS, Kim KS, Lee HY, Chung SH, Kim DS. A study of glomerular minimal lesion and minimal mesangial proliferation with or without nephrotic syndrome; pathologic, immunopathologic and clinical correlations. Yonsei Med J 1986; 27:17-24. [PMID: 3300054 DOI: 10.3349/ymj.1986.27.1.17] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/05/2023] Open
|
194
|
|
195
|
|
196
|
Choi IJ, Seong BY, Kim TS, Lee YB. An experimental study on immune complex induced arthritis in rabbits--reference to macrophages and M-type cells of the synovium. Yonsei Med J 1984; 25:133-41. [PMID: 6242486 DOI: 10.3349/ymj.1984.25.2.133] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/19/2023] Open
|
197
|
|
198
|
Kim PK, Kim NA, Kim KS, Choi IJ. Steroid effects on minimal lesion nephrotic syndrome with and without immune deposits. Int J Pediatr Nephrol 1982; 3:257-61. [PMID: 7166452] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
A comparison was done between the two groups of MLNS (minimal lesion nephrotic syndrome) with and without mesangial deposits of immunoglobulin and complement. The subjects were 40 patients with MLNS whose kidney could be obtained by biopsy. No significant differences were found between the two groups in selective protein index, serum cholesterol level, serum albumin level, amount of 24 hour urine protein, hematuria, serum immunoglobulin level and response to steroid therapy. Ig M was deposited in eleven of fourteen patients with MLNS, Ig G three of fourteen, C3 thirteen of fourteen. There was no relationship between serum level and glomerular deposition of immunoglobulin and complement.
Collapse
|
199
|
Kim PK, Kim KS, Kim YH, Lee JY, Choi IJ. Incidence of positive serum hepatitis B surface antigen and its antibody in renal diseases of children. Yonsei Med J 1982; 23:110-7. [PMID: 7187146 DOI: 10.3349/ymj.1982.23.2.110] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/23/2023] Open
|
200
|
|